351 related articles for article (PubMed ID: 19692124)
1. Complement factor H Y402H and C-reactive protein polymorphism and photodynamic therapy response in age-related macular degeneration.
Feng X; Xiao J; Longville B; Tan AX; Wu XN; Cooper MN; McAllister IL; Isaacs T; Palmer LJ; Constable IJ
Ophthalmology; 2009 Oct; 116(10):1908-12.e1. PubMed ID: 19692124
[TBL] [Abstract][Full Text] [Related]
2. An analysis of the CFH Y402H genotype in AMD patients and controls from the UK, and response to PDT treatment.
Goverdhan SV; Hannan S; Newsom RB; Luff AJ; Griffiths H; Lotery AJ
Eye (Lond); 2008 Jun; 22(6):849-54. PubMed ID: 17464302
[TBL] [Abstract][Full Text] [Related]
3. A prospective assessment of the Y402H variant in complement factor H, genetic variants in C-reactive protein, and risk of age-related macular degeneration.
Schaumberg DA; Christen WG; Kozlowski P; Miller DT; Ridker PM; Zee RY
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2336-40. PubMed ID: 16723442
[TBL] [Abstract][Full Text] [Related]
4. The effect of complement factor H Y402H polymorphism on the outcome of photodynamic therapy in age-related macular degeneration.
Seitsonen SP; Jarvela IE; Meri S; Tommila PV; Ranta PH; Immonen IJ
Eur J Ophthalmol; 2007; 17(6):943-9. PubMed ID: 18050121
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of CRP, CFH Y402H and environmental risk factors on risk of neovascular age-related macular degeneration.
Kim IK; Ji F; Morrison MA; Adams S; Zhang Q; Lane AM; Capone A; Dryja TP; Ott J; Miller JW; DeAngelis MM
Mol Vis; 2008 Aug; 14():1487-95. PubMed ID: 18704199
[TBL] [Abstract][Full Text] [Related]
6. Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to photodynamic therapy.
Brantley MA; Edelstein SL; King JM; Plotzke MR; Apte RS; Kymes SM; Shiels A
Eye (Lond); 2009 Mar; 23(3):626-31. PubMed ID: 18292785
[TBL] [Abstract][Full Text] [Related]
7. Complement factor H and high-temperature requirement A-1 genotypes and treatment response of age-related macular degeneration.
Tsuchihashi T; Mori K; Horie-Inoue K; Gehlbach PL; Kabasawa S; Takita H; Ueyama K; Okazaki Y; Inoue S; Awata T; Katayama S; Yoneya S
Ophthalmology; 2011 Jan; 118(1):93-100. PubMed ID: 20678803
[TBL] [Abstract][Full Text] [Related]
8. Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab.
Brantley MA; Fang AM; King JM; Tewari A; Kymes SM; Shiels A
Ophthalmology; 2007 Dec; 114(12):2168-73. PubMed ID: 18054635
[TBL] [Abstract][Full Text] [Related]
9. Association of complement factor H Y402H polymorphism with phenotype of neovascular age related macular degeneration in Israel.
Chowers I; Cohen Y; Goldenberg-Cohen N; Vicuna-Kojchen J; Lichtinger A; Weinstein O; Pollack A; Axer-Siegel R; Hemo I; Averbukh E; Banin E; Meir T; Lederman M
Mol Vis; 2008; 14():1829-34. PubMed ID: 18852870
[TBL] [Abstract][Full Text] [Related]
10. Genetic predictors of response to photodynamictherapy.
Parmeggiani F; Gemmati D; Costagliola C; Semeraro F; Perri P; D'Angelo S; Romano MR; De Nadai K; Sebastiani A; Incorvaia C
Mol Diagn Ther; 2011 Aug; 15(4):195-210. PubMed ID: 21913742
[TBL] [Abstract][Full Text] [Related]
11. [Association between Y402H, E318D and R102G polymorphisms of complement proteins genes and the response to intravitreal anti-VEGF treatment in patients with neovascular age-related macular degeneration].
Kubicka-Trząska A; Karska-Basta I; Kobylarz J; Dziedzina S; Sanak M; Romanowska-Dixon B
Klin Oczna; 2016; 118(2):114-21. PubMed ID: 29912491
[TBL] [Abstract][Full Text] [Related]
12. Predictive role of coagulation-balance gene polymorphisms in the efficacy of photodynamic therapy with verteporfin for classic choroidal neovascularization secondary to age-related macular degeneration.
Parmeggiani F; Costagliola C; Gemmati D; D'Angelo S; Perri P; Scapoli GL; Catozzi L; Federici F; Sebastiani A; Incorvaia C
Pharmacogenet Genomics; 2007 Dec; 17(12):1039-46. PubMed ID: 18004208
[TBL] [Abstract][Full Text] [Related]
13. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration.
Despriet DD; Klaver CC; Witteman JC; Bergen AA; Kardys I; de Maat MP; Boekhoorn SS; Vingerling JR; Hofman A; Oostra BA; Uitterlinden AG; Stijnen T; van Duijn CM; de Jong PT
JAMA; 2006 Jul; 296(3):301-9. PubMed ID: 16849663
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics of Complement Factor H Y402H Polymorphism and Treatment of Neovascular AMD with Anti-VEGF Agents: A Meta-Analysis.
Chen G; Tzekov R; Li W; Jiang F; Mao S; Tong Y
Sci Rep; 2015 Sep; 5():14517. PubMed ID: 26411831
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy in VEGF inhibition non-responders-Pharmacogenetic study in age-related macular degeneration assessed with swept-source optical coherence tomography.
Teper SJ; Nowinska A; Pilat J; Wylegala E
Photodiagnosis Photodyn Ther; 2016 Mar; 13():108-113. PubMed ID: 26780119
[TBL] [Abstract][Full Text] [Related]
16. Effect of Factor XIII-A G185T Polymorphism on Visual Prognosis after Photodynamic Therapy for Neovascular Macular Degeneration.
Parmeggiani F; Costagliola C; Semeraro F; Romano MR; Rinaldi M; Gallenga CE; Serino ML; Incorvaia C; D'Angelo S; De Nadai K; Dell'Omo R; Russo A; Gemmati D; Perri P
Int J Mol Sci; 2015 Aug; 16(8):19796-811. PubMed ID: 26307969
[TBL] [Abstract][Full Text] [Related]
17. Impact of coagulation-balance gene predictors on efficacy of photodynamic therapy for choroidal neovascularization in pathologic myopia.
Parmeggiani F; Gemmati D; Costagliola C; Semeraro F; D'Angelo S; Perri P; Sebastiani A; Incorvaia C
Ophthalmology; 2010 Mar; 117(3):517-23. PubMed ID: 20044141
[TBL] [Abstract][Full Text] [Related]
18. Association of the Y402H polymorphism in complement factor H gene and neovascular age-related macular degeneration in Chinese patients.
Lau LI; Chen SJ; Cheng CY; Yen MY; Lee FL; Lin MW; Hsu WM; Wei YH
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3242-6. PubMed ID: 16877387
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor gene variation and the response to photodynamic therapy in age-related macular degeneration.
Immonen I; Seitsonen S; Tommila P; Kangas-Kontio T; Kakko S; Savolainen ER; Savolainen MJ; Liinamaa MJ
Ophthalmology; 2010 Jan; 117(1):103-8. PubMed ID: 19896188
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein and complement factor H polymorphism interaction in advanced exudative age-related macular degeneration.
Soheilian R; Jabbarpour Bonyadi MH; Moein H; Babanejad M; Ramezani A; Yaseri M; Soheilian M
Int Ophthalmol; 2017 Oct; 37(5):1161-1168. PubMed ID: 27778189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
